US Stock MarketDetailed Quotes

ATXS Astria Therapeutics Inc

Watchlist
  • 9.520
  • -0.290-2.96%
Close Dec 13 16:00 ET
  • 9.520
  • 0.0000.00%
Post 16:47 ET
537.25MMarket Cap-4.37P/E (TTM)

Astria Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-96.14%-27.97M
-56.98%-16.79M
-44.07%-19.09M
-57.23%-68.45M
-183.55%-30.24M
-39.12%-14.26M
-6.31%-10.7M
-5.53%-13.25M
-44.38%-43.53M
-69.65%-10.66M
Net income from continuing operations
-38.40%-24.53M
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.69%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
Operating gains losses
----
----
----
----
----
----
----
----
2,071.83%1.54M
--0
Other non cash items
116.35%344K
389.12%944K
-541.38%-512K
223.30%545K
113.53%77K
231.25%159K
22.15%193K
246.84%116K
-100.27%-442K
-198.44%-569K
Change In working capital
-439.36%-5.48M
1,171.53%5.49M
58.60%-1.41M
-191.16%-2.41M
-150.60%-1.06M
196.51%1.62M
608.24%432K
-3,796.74%-3.4M
168.27%2.65M
65.09%2.1M
-Change in prepaid assets
-308.70%-4.56M
112.71%1.41M
-7.64%-930K
-189.92%-4.55M
-193.45%-3.23M
-61.13%-1.12M
983.61%661K
-630.06%-864K
-1,944.71%-1.57M
-193.46%-1.1M
-Change in payables and accrued expense
-126.89%-776K
5,508.97%4.22M
86.75%-317K
-24.66%2.74M
-12.02%2.33M
144.16%2.89M
40.00%-78K
-4,171.43%-2.39M
210.97%3.64M
290.69%2.65M
-Change in other current liabilities
2.58%-151K
12.58%-132K
-11.03%-161K
-206.27%-610K
-128.91%-159K
-381.82%-155K
-843.75%-151K
-866.67%-145K
184.29%574K
--550K
Cash from discontinued investing activities
Operating cash flow
-96.14%-27.97M
-56.98%-16.79M
-44.07%-19.09M
-57.23%-68.45M
-183.55%-30.24M
-39.12%-14.26M
-6.31%-10.7M
-5.53%-13.25M
-44.38%-43.53M
-69.65%-10.66M
Investing cash flow
Cash flow from continuing investing activities
154,800.00%6.19M
-17.58%-68.1M
-164.74%-126.23M
180.81%135.05M
98.51%-2.02M
-100.21%-4K
-751.76%-57.92M
819.55%194.99M
-1,231.17%-167.13M
-246.62%-135.18M
Net PPE purchase and sale
-400.00%-20K
---305K
--0
72.53%-25K
48.39%-16K
93.10%-4K
--0
---5K
-333.33%-91K
---31K
Net investment purchase and sale
--6.21M
-17.05%-67.8M
-164.73%-126.23M
180.87%135.08M
98.52%-2M
--0
-752.02%-57.92M
819.57%195M
-779.15%-167.04M
-246.54%-135.15M
Cash from discontinued investing activities
Investing cash flow
154,800.00%6.19M
-17.58%-68.1M
-164.74%-126.23M
180.81%135.05M
98.51%-2.02M
-100.21%-4K
-751.76%-57.92M
819.55%194.99M
-1,231.17%-167.13M
-246.62%-135.18M
Financing cash flow
Cash flow from continuing financing activities
13,810.00%15.3M
-65.57%94K
383,162.16%141.81M
-38.92%88.4M
-26.93%87.98M
-99.55%110K
273K
37K
38.78%144.72M
708,117.65%120.4M
Net common stock issuance
--15.24M
--0
--137.17M
-39.17%87.98M
-26.90%87.98M
--0
--0
--0
38.73%144.64M
--120.35M
Proceeds from stock option exercised by employees
-47.27%58K
-65.57%94K
12,421.62%4.63M
400.00%420K
--0
223.53%110K
--273K
--37K
265.22%84K
194.12%50K
Cash from discontinued financing activities
Financing cash flow
13,810.00%15.3M
-65.57%94K
383,162.16%141.81M
-38.92%88.4M
-26.93%87.98M
-99.55%110K
--273K
--37K
38.78%144.72M
708,117.65%120.4M
Net cash flow
Beginning cash position
-34.85%87.38M
-14.96%172.18M
749.25%175.69M
-76.12%20.69M
160.04%119.97M
345.44%134.12M
331.04%202.46M
-76.12%20.69M
245.81%86.63M
-65.02%46.14M
Current changes in cash
54.24%-6.48M
-24.08%-84.8M
-101.94%-3.52M
335.07%155.01M
318.98%55.72M
-188.31%-14.15M
-305.33%-68.34M
558.36%181.78M
-207.09%-65.94M
43.79%-25.45M
End cash Position
-32.57%80.9M
-34.85%87.38M
-14.96%172.18M
749.25%175.69M
749.25%175.69M
160.04%119.97M
345.44%134.12M
331.04%202.46M
-76.12%20.69M
-76.12%20.69M
Free cash flow
-96.22%-27.99M
-59.84%-17.1M
-44.02%-19.09M
-56.95%-68.47M
-182.88%-30.25M
-38.37%-14.26M
-6.29%-10.7M
-5.57%-13.26M
-44.58%-43.62M
-70.14%-10.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -96.14%-27.97M-56.98%-16.79M-44.07%-19.09M-57.23%-68.45M-183.55%-30.24M-39.12%-14.26M-6.31%-10.7M-5.53%-13.25M-44.38%-43.53M-69.65%-10.66M
Net income from continuing operations -38.40%-24.53M-92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.69%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M
Operating gains losses --------------------------------2,071.83%1.54M--0
Other non cash items 116.35%344K389.12%944K-541.38%-512K223.30%545K113.53%77K231.25%159K22.15%193K246.84%116K-100.27%-442K-198.44%-569K
Change In working capital -439.36%-5.48M1,171.53%5.49M58.60%-1.41M-191.16%-2.41M-150.60%-1.06M196.51%1.62M608.24%432K-3,796.74%-3.4M168.27%2.65M65.09%2.1M
-Change in prepaid assets -308.70%-4.56M112.71%1.41M-7.64%-930K-189.92%-4.55M-193.45%-3.23M-61.13%-1.12M983.61%661K-630.06%-864K-1,944.71%-1.57M-193.46%-1.1M
-Change in payables and accrued expense -126.89%-776K5,508.97%4.22M86.75%-317K-24.66%2.74M-12.02%2.33M144.16%2.89M40.00%-78K-4,171.43%-2.39M210.97%3.64M290.69%2.65M
-Change in other current liabilities 2.58%-151K12.58%-132K-11.03%-161K-206.27%-610K-128.91%-159K-381.82%-155K-843.75%-151K-866.67%-145K184.29%574K--550K
Cash from discontinued investing activities
Operating cash flow -96.14%-27.97M-56.98%-16.79M-44.07%-19.09M-57.23%-68.45M-183.55%-30.24M-39.12%-14.26M-6.31%-10.7M-5.53%-13.25M-44.38%-43.53M-69.65%-10.66M
Investing cash flow
Cash flow from continuing investing activities 154,800.00%6.19M-17.58%-68.1M-164.74%-126.23M180.81%135.05M98.51%-2.02M-100.21%-4K-751.76%-57.92M819.55%194.99M-1,231.17%-167.13M-246.62%-135.18M
Net PPE purchase and sale -400.00%-20K---305K--072.53%-25K48.39%-16K93.10%-4K--0---5K-333.33%-91K---31K
Net investment purchase and sale --6.21M-17.05%-67.8M-164.73%-126.23M180.87%135.08M98.52%-2M--0-752.02%-57.92M819.57%195M-779.15%-167.04M-246.54%-135.15M
Cash from discontinued investing activities
Investing cash flow 154,800.00%6.19M-17.58%-68.1M-164.74%-126.23M180.81%135.05M98.51%-2.02M-100.21%-4K-751.76%-57.92M819.55%194.99M-1,231.17%-167.13M-246.62%-135.18M
Financing cash flow
Cash flow from continuing financing activities 13,810.00%15.3M-65.57%94K383,162.16%141.81M-38.92%88.4M-26.93%87.98M-99.55%110K273K37K38.78%144.72M708,117.65%120.4M
Net common stock issuance --15.24M--0--137.17M-39.17%87.98M-26.90%87.98M--0--0--038.73%144.64M--120.35M
Proceeds from stock option exercised by employees -47.27%58K-65.57%94K12,421.62%4.63M400.00%420K--0223.53%110K--273K--37K265.22%84K194.12%50K
Cash from discontinued financing activities
Financing cash flow 13,810.00%15.3M-65.57%94K383,162.16%141.81M-38.92%88.4M-26.93%87.98M-99.55%110K--273K--37K38.78%144.72M708,117.65%120.4M
Net cash flow
Beginning cash position -34.85%87.38M-14.96%172.18M749.25%175.69M-76.12%20.69M160.04%119.97M345.44%134.12M331.04%202.46M-76.12%20.69M245.81%86.63M-65.02%46.14M
Current changes in cash 54.24%-6.48M-24.08%-84.8M-101.94%-3.52M335.07%155.01M318.98%55.72M-188.31%-14.15M-305.33%-68.34M558.36%181.78M-207.09%-65.94M43.79%-25.45M
End cash Position -32.57%80.9M-34.85%87.38M-14.96%172.18M749.25%175.69M749.25%175.69M160.04%119.97M345.44%134.12M331.04%202.46M-76.12%20.69M-76.12%20.69M
Free cash flow -96.22%-27.99M-59.84%-17.1M-44.02%-19.09M-56.95%-68.47M-182.88%-30.25M-38.37%-14.26M-6.29%-10.7M-5.57%-13.26M-44.58%-43.62M-70.14%-10.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data